Wockhardt Ltd. - Research Center
532300 WOCKPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 77.00 | 72.00 | 72.00 | 55.39 | 55.37 |
| Share application money | - | 16.00 | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 1,719.00 | 1,665.00 | 2,140.00 | 1,550.37 | 939.25 |
| Loan funds | |||||
| Secured loans | 1,790.00 | 1,620.00 | 1,590.00 | 1,325.56 | 1,400.30 |
| Unsecured loans | - | - | - | - | - |
| Total | 3,586.00 | 3,373.00 | 3,802.00 | 2,931.32 | 2,394.92 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 3,142.00 | 3,170.00 | 3,044.00 | 2,811.32 | 3,096.15 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 1,693.00 | 1,545.00 | 1,216.00 | 1,127.66 | 1,051.80 |
| Net block | 1,449.00 | 1,625.00 | 1,828.00 | 1,683.66 | 2,044.35 |
| Capital work-in-progress | 833.00 | 823.00 | 825.00 | 715.70 | 305.29 |
| Investments | 297.00 | 297.00 | 297.00 | 297.27 | 297.27 |
| Net current assets | |||||
| Current assets, loans & advances | 2,289.00 | 1,987.00 | 2,848.00 | 2,198.27 | 2,112.60 |
| Less : current liabilities & provisions | 1,282.00 | 1,359.00 | 1,996.00 | 1,963.58 | 2,364.59 |
| Total net current assets | 1,007.00 | 628.00 | 852.00 | 234.69 | -251.99 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 3,586.00 | 3,373.00 | 3,802.00 | 2,931.32 | 2,394.92 |
| Notes: | |||||
| Book value of unquoted investments | 297.00 | - | - | 0.45 | 0.45 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 935.46 | 898.26 | 25.00 | 577.94 | 1,511.84 |
| Number of equity sharesoutstanding (Lacs) | 1534.01 | 1440.88 | 1440.60 | 1107.81 | 1106.86 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis